Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Armata Pharmaceuticals (ARMP) Return on Capital Employed (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Return on Capital Employed for 5 consecutive years, with 1.23% as the latest value for Q3 2018.

  • Quarterly Return on Capital Employed rose 92.0% to 1.23% in Q3 2018 from the year-ago period, while the trailing twelve-month figure was 1.23% through Sep 2018, up 92.0% year-over-year, with the annual reading at 1.27% for FY2017, 18.0% down from the prior year.
  • Return on Capital Employed hit 1.23% in Q3 2018 for Armata Pharmaceuticals, down from 0.82% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.3% in Q3 2015 to a low of 2.58% in Q2 2017.
  • Historically, Return on Capital Employed has averaged 0.91% across 5 years, with a median of 0.53% in 2016.
  • Biggest five-year swings in Return on Capital Employed: tumbled -205bps in 2017 and later soared 176bps in 2018.
  • Year by year, Return on Capital Employed stood at 0.5% in 2014, then soared by 32bps to 0.34% in 2015, then plummeted by -274bps to 1.26% in 2016, then fell by -22bps to 1.54% in 2017, then grew by 20bps to 1.23% in 2018.
  • Business Quant data shows Return on Capital Employed for ARMP at 1.23% in Q3 2018, 0.82% in Q2 2018, and 1.44% in Q1 2018.